Compound Global Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-164
Closed -$57.5K 32
2025
Q4
$57.5K Hold
164
3.19% 13
2025
Q3
$53K Hold
164
2.88% 14
2025
Q2
$63.8K Sell
164
-820
-83% -$330K 5.82% 10
2025
Q1
$391K Sell
984
-2,100
-68% -$843K 2.31% 17
2024
Q4
$1.14M Buy
+3,084
New +$1.29M 4.63% 6

Other funds holding ELV

Compound Global Advisors's ELV Position: Q1 2026 in Review

Compound Global Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 164 shares — an estimated $57.5K sold.

Compound Global Advisors first reported a position in ELV in Q4 2024 and held it in 5 quarters. The position peaked at $1.14M in Q4 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Compound Global Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Compound Global Advisors sold 164 Elevance Health shares in Q1 2026, an estimated $57.5K.
  • Compound Global Advisors first reported a position in Elevance Health in Q4 2024 and held it in 5 quarters.
  • Compound Global Advisors's Elevance Health position peaked at $1.14M in Q4 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Compound Global Advisors's 13F filing for Q1 2026, filed 7 May 2026.